Dec 15 (Reuters) - Barclays Plc said on Tuesday ithad hired two senior dealmakers in the United States as it seeksto expand its healthcare investment banking group amid a frenzyof dealmaking in the sector. Ben Taylor, previously head of emerging pharmaceuticalcompanies at Goldman Sachs Group Inc, has joinedBarclays' team in New York. He has a 15-year career spanning New York, California, Europe and Asia. In one of his previousroles, he was co-head of healthcare for Goldman's China andSouth East Asia investment banking business. Christine Poon, previously a vice chair and worldwide chairof pharmaceuticals at Johnson & Johnson Inc, was namedsenior adviser to Barclays' healthcare banking group. She willbe responsible for further developing relationships andstrategic dialogue with key healthcare clients. After retiring from Johnson & Johnson, Poon spent five yearsas dean of the Max M. Fisher College of Business at the OhioState University, the first to be appointed directly from theprivate sector since the institution was founded in 1916. Before joining Johnson & Johnson, Poon spent 15 years atBristol-Myers Squibb Co in various roles includingpresident of international medicines. Other recent additions to the Barclays healthcare teaminclude Jason Truman, who left Morgan Stanley earlierthis year to join the British bank in New York. Barclays has lost talent too in what has been a record yearfor healthcare mergers, led by Pfizer Inc's $160 billionacquisition of Allergan Plc. Earlier this year, a groupof five healthcare bankers led by Punit Mehta left Barclays towork at Credit Suisse Group AG. Nevertheless, Barclays has had a role on several of thisyear's top healthcare deals, including advising TevaPharmaceutical Industries Ltd on its acquisition of ageneric drug portfolio of Allergan for $40.5 billion. (Reporting by Greg Roumeliotis in New York; Editing by MatthewLewis)
Norway wealth fund to back Barclays CEO, chair at AGM
OSLO, May 4 (Reuters) - Norway's $1.6 trillion sovereign wealth fund, one of the world's largest investors, supports the reappointment of Barclays CEO C.S. Venkatakrishnan and Chair Nigel Higgins to the British bank's board, the fund manager said on Saturday.
Read more